MARKET

AZN

AZN

Astrazeneca Plc
NASDAQ
90.61
+0.75
+0.83%
After Hours: 90.59 -0.02 -0.02% 17:00 12/18 EST
OPEN
90.29
PREV CLOSE
89.86
HIGH
91.17
LOW
90.19
VOLUME
6.83M
TURNOVER
--
52 WEEK HIGH
94.02
52 WEEK LOW
60.82
MARKET CAP
281.02B
P/E (TTM)
30.10
1D
5D
1M
3M
1Y
5Y
1D
J&J wins FDA nod for Rybrevant injectable in lung cancer
Seeking Alpha · 10h ago
AstraZeneca, Daiichi Sankyo get EMA validation of Datroway Type II Variation MAA
TipRanks · 12h ago
Daiichi Sankyo And AstraZeneca's DATROWAY EU Application Validated For First Line Metastatic TNBC Without Immunotherapy Option Supported By TROPION-Breast02 OS And PFS Improvements
Benzinga · 15h ago
EMA Validates Daiichi Sankyo and AstraZeneca Application for DATROWAY in First-Line Treatment of Metastatic Triple Negative Breast Cancer
Reuters · 15h ago
UPDATE 3-AbbVie, several other pharma companies near MFN deal with Trump, sources say
Reuters · 1d ago
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
TipRanks · 1d ago
More pharmas expected to sign drug pricing deals with Trump on Friday - report
Seeking Alpha · 1d ago
UK’s $49 Billion R&D Plan Puts Quantum Tech on Investors’ Radar
TipRanks · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (ADR) stock information, including NASDAQ: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.